The short version
- A meta-analysis of 54 randomised trials found that when rated by people who knew what the child was taking, every dietary and psychological ADHD intervention appeared to work, but under the best probably blinded assessment only free fatty acid supplementation (SMD 0.16) and artificial food colour exclusion (SMD 0.42) remained significant.
- A meta-analysis of 10 trials in 699 children found omega-3 supplementation produced a small but significant improvement in ADHD symptom ratings, which the authors described as modest compared with psychostimulants, atomoxetine or alpha-2 agonists.
- In the MADDY trial of 135 children, 54% of the micronutrient group were responders on blinded clinician-rated global improvement versus 18% on placebo, while the parent-rated symptom composite showed no significant difference between groups.
- A separate meta-analysis of omega-3 supplementation found no improvement in cognitive performance in children with ADHD and related disorders, which is a different question from symptom ratings.
- ADHD is a medical diagnosis requiring clinical assessment, and no dietary supplement treats, cures, prevents or diagnoses it.
Start with the part that is not negotiable. ADHD is a medical diagnosis, made by a clinician, and it has established treatments that are considerably more effective than anything discussed below. No dietary supplement treats, cures, prevents or diagnoses it, and nothing in this article should be read as suggesting one does. We sell nothing for ADHD and we are not trying to.
What we can do is read the trials honestly, because people ask us about them constantly, and because most of what is written about supplements and ADHD online is either a sales page or a dismissal. The real literature is more specific than either, and the most useful thing in it is a lesson about who was doing the rating.
The blinding problem, quantified
In 2013 the European ADHD Guidelines Group did something unusually clarifying. They meta-analysed 54 randomised trials of non-drug treatments — restricted elimination diets, artificial food colour exclusion, free fatty acid supplementation, cognitive training, neurofeedback and behavioural interventions — and then analysed them twice.
Analysis one used the ratings from people closest to the treatment, usually parents and teachers who knew what the child was taking. On those ratings, everything worked: dietary interventions at standardised mean differences of 0.21 to 0.48, psychological ones at 0.40 to 0.64.
Analysis two used the best probably blinded assessment available in each trial. On those, two things survived: free fatty acid supplementation at SMD 0.16 and artificial food colour exclusion at 0.42. Everything else — behavioural interventions, neurofeedback, brain training, restricted elimination diets — was attenuated to non-significance.
That is the single most important number set in this field. It is not that the parents were lying. It is that expectation moves a subjective rating, and a symptom scale filled in by someone hoping the new thing is helping is not a measurement of the new thing. Any supplement study you read about ADHD should be checked for who scored it.
Omega-3, the one that survives
Free fatty acid supplementation means, in practice, omega-3. A Yale meta-analysis pooled ten randomised placebo-controlled trials in 699 children and found a small but statistically significant improvement in ADHD symptom ratings. The dose of EPA within the supplement correlated with efficacy. No publication bias or heterogeneity was detected.
The authors then said the thing that keeps this honest: the effect is modest compared with currently available pharmacotherapies — psychostimulants, atomoxetine, alpha-2 agonists. Their suggested role is as an addition to standard treatment, or for families who have declined the other options, with the benign side effect profile as the argument. That is a careful, appropriately small recommendation from a child psychiatry group, and it is not the same sentence as "omega-3 helps ADHD".
Worth noting alongside it: when a separate meta-analysis looked at whether omega-3 improved cognitive performance in children with ADHD and related disorders, it found no effect in that subgroup. The symptom-rating effect and a cognitive effect are different claims, and only the first has support. That is the same conditional pattern that runs through omega-3 and cognition generally.
The micronutrient trial that split down the middle
The best recent test of a broad vitamin-and-mineral formula is MADDY: 135 unmedicated children aged 6 to 12 with ADHD and at least one impairing irritability symptom, randomised across three sites for eight weeks, with blinding verified as maintained.
It had two pre-declared primary outcomes and they disagreed. On blinded clinician global improvement, 54% of the micronutrient group were responders versus 18% on placebo (risk ratio 2.97, 97.5% CI 1.50 to 5.90, P < 0.001). On the parent-rated symptom composite, both groups improved and the difference between them was not significant (effect size 0.07, P = 0.70).
Two well-run measures, one clearly positive and one clearly null, in the same children, at the same time. The trial also found the micronutrient group grew 6mm more than placebo over eight weeks, and reported no serious adverse events.
Anyone who tells you this trial proves micronutrients work for ADHD is quoting half of it. Anyone who tells you it proves they do not is quoting the other half.
What this means if it is you or your child
The sequence matters more than the shopping list.
- Get assessed properly. Inattention has many causes and several of them are not ADHD. Short sleep produces an almost identical picture of attention lapses, and the sleep debt research puts the effect size well above anything here.
- Do not stop or reduce a prescribed medicine to try a supplement. That decision belongs with the prescriber, and the trials above compare supplements to placebo, never to standard treatment.
- Tell your clinician what you are taking. Including fish oil. Especially if there is any bleeding risk or surgery planned.
- Be sceptical of your own ratings. The blinding analysis is a warning about all of us, not about other people. If you start something new, ask a teacher or a colleague who does not know about it what they have noticed.
What we'd actually tell you
If you have a diagnosis and a treatment that is working, the honest read of this literature is that the marginal supplement is unlikely to add much, and that omega-3 is the only one with an effect that survived blinding. If you eat no oily fish, that is worth correcting for nutritional reasons regardless.
If you do not have a diagnosis and you are self-treating a suspicion, please get assessed. That is not us being cautious for legal reasons. It is that a real diagnosis opens real options, and the alternative is spending years and a lot of money on interventions whose blinded effect sizes are 0.16.
We would rather lose the sale to a clinic than take it for a capsule.
Good questions
Can supplements treat ADHD?
No. ADHD is a medical diagnosis and no dietary supplement treats, cures or prevents it. The trial literature shows one small effect that survives blinded assessment, from omega-3, at a standardised mean difference of 0.16. Assessment and established treatment come first, and that conversation belongs with a clinician.
Does omega-3 help with ADHD symptoms?
Modestly, on symptom ratings, in children. Ten randomised trials in 699 children found a small but significant improvement, with higher EPA doses correlating with better results. The authors positioned it as an addition to standard treatment or an option for families declining other treatments, not as a replacement for them.
Why do supplements seem to work when parents rate them?
Because unblinded ratings measure expectation as well as symptoms. In a meta-analysis of 54 trials, every dietary and psychological intervention looked effective when scored by people who knew what was being given, and most of those effects vanished under blinded assessment. This applies to everyone, including careful, honest observers.
Should I try a supplement before seeing a doctor about attention problems?
No, and the reason is practical rather than cautious. Inattention has several causes, short sleep chief among them, and a real assessment opens real options. Self-treating a suspicion for six months costs money and delays the thing most likely to help. Get assessed, then decide about supplements with someone who knows your history.
Can I take a supplement alongside ADHD medication?
That is a question for your prescriber, and you should ask before starting anything. Never reduce or stop a prescribed medicine to test a supplement. Tell the clinician what you are taking, including fish oil, particularly if there is any bleeding risk or surgery planned. The trials compared supplements with placebo, never with medication.
Do multivitamins or micronutrients help with ADHD?
The best trial split down the middle. In 135 children, blinded clinician ratings found 54% responders on micronutrients against 18% on placebo, while parent-rated symptom scores showed no difference between groups. That is one positive and one null outcome in the same study, which is a reason for caution rather than confidence.
Sources
- Sonuga-Barke EJ, Brandeis D, Cortese S, et al. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry, 2013. View study
- Bloch MH, Qawasmi A. Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry, 2011. View study
- Johnstone JM, Hatsu I, Tost G, et al. Micronutrients for Attention-Deficit/Hyperactivity Disorder in Youths: A Placebo-Controlled Randomized Clinical Trial. J Am Acad Child Adolesc Psychiatry, 2022. View study
- Cooper RE, Tye C, Kuntsi J, Vassos E, Asherson P. Omega-3 polyunsaturated fatty acid supplementation and cognition: A systematic review and meta-analysis. J Psychopharmacol, 2015. View study
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
